🇺🇸 FDA
Patent

US 10828376

Liver-specific constructs and methods of use thereof

granted A61KA61K38/00A61K38/37

Quick answer

US patent 10828376 (Liver-specific constructs and methods of use thereof) held by Sangamo Therapeutics, Inc. expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Therapeutics, Inc.
Grant date
Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/00, A61K38/37, A61K45/06, A61K48/00